NCT07615790

Brief Summary

The goal of this clinical trial is to learn whether a structured combined exercise program can improve heart health, menopausal symptoms, sleep quality, and quality of life in postmenopausal women aged 45 to 65 years. The main questions it aims to answer are: Does the exercise program improve heart rate variability, which shows how well the heart is controlled by the nervous system? Does the exercise program lower menopausal symptoms? Does the exercise program improve sleep quality and quality of life? Researchers will compare women who join the exercise program with women who continue their usual daily activities. Participants in the exercise group will take part in a supervised exercise program for 12 weeks. They will exercise 2 days each week. Each session will last 45 minutes and will include warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises. Participants in the control group will continue their usual daily activities during the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Apr 2026Sep 2026

Study Start

First participant enrolled

April 27, 2026

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 12, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

May 29, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

May 12, 2026

Last Update Submit

May 28, 2026

Conditions

Keywords

Structured combined exercisePostmenopausal womenHeart rate variabilityCardiac autonomic functionMenopausal symptomsSleep qualityQuality of life

Outcome Measures

Primary Outcomes (1)

  • Heart Rate Variability

    Cardiac autonomic nervous system function will be assessed using heart rate variability parameters including standard deviation of normal-to-normal intervals (SDNN), root mean square of successive differences (RMSSD), low-frequency power (LF), high-frequency power (HF), and low-frequency/high-frequency ratio (LF/HF ratio).

    Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention

Secondary Outcomes (5)

  • Menopause Rating Scale

    Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention

  • Sleep Quality

    Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention

  • Menopause-Specific Quality of Life

    Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention

  • Depressive Symptoms

    Baseline, immediately after the 12-week intervention, and 8 weeks after the intervention

  • Hot Flash Frequency and Severity

    Daily throughout the 12-week intervention period and daily during the 8-week post-intervention follow-up period

Study Arms (2)

Exercise Group

EXPERIMENTAL

Participants will receive a 12-week structured combined exercise program performed twice weekly under physiotherapist supervision.

Behavioral: Structured Combined Exercise Program

Control Group

NO INTERVENTION

Participants in the control group will continue their usual daily activities and will not receive any structured exercise intervention during the study period. At the end of the study, participants in the control group will be informed about the exercise program, and volunteers will be offered the opportunity to participate in the program in accordance with ethical considerations.

Interventions

The intervention consists of a supervised 12-week structured combined exercise program performed twice weekly. Each 45-minute session includes warm-up, balance, strengthening, coordination, flexibility, and cool-down exercises.

Exercise Group

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women in the postmenopausal period
  • Aged between 45 and 65 years
  • Able to communicate and cooperate with the researchers
  • Not participating in another structured exercise program
  • Willing to participate voluntarily in the study

You may not qualify if:

  • Presence of severe cardiovascular, neurological, orthopedic, or psychiatric disease
  • Hormone replacement therapy use during the study period
  • Cognitive impairment affecting participation
  • Uncontrolled hypertension or other unstable medical conditions
  • Regular participation in structured exercise training within the last 6 months
  • Smoking or alcohol use that may affect heart rate variability measurements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fenerbahce University

Istanbul, Atasehir, Turkey (Türkiye)

RECRUITING

Related Publications (1)

  • Yilmaz Babacan G, Guler Cekic S, Algun ZC, Durmusoglu AF. Effects of exercise training on vasomotor symptoms and quality of life in postmenopausal women: a randomized controlled trial. BMC Womens Health. 2025 Dec 22;25(1):612. doi: 10.1186/s12905-025-04231-y.

MeSH Terms

Conditions

Autonomic Nervous System DiseasesSleep Wake DisordersSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersSleep Disorders, IntrinsicDyssomnias

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to either the exercise intervention group or the control group in a parallel design. The intervention group will receive a structured combined exercise program for 12 weeks, while the control group will continue their usual daily activities.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 12, 2026

First Posted

May 29, 2026

Study Start

April 27, 2026

Primary Completion

July 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

May 29, 2026

Record last verified: 2026-05

Locations